Dimers Vc1.1-dimer, RgIA-dimer and PeIA-dimer
A technology of vc1.1-dimer and dimer, which is applied in the field of medicine, can solve the problems of insufficient drug production and decreased activity.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0014] The present invention will be described in detail below in combination with specific embodiments.
[0015] Dimeric α-conotoxin Vc1.1, RgIA and PeIA are polypeptide compounds. By designing a linker containing two alkyne functional groups, modifying the wild-type polypeptide, introducing azide functional groups, and then through the click reaction Thus Vc1.1-dimer, RgIA-dimer and PeIA-dimer were synthesized.
[0016] Its structure is as attached Figure 1-3 Shown (the amino acid structure is represented by the abbreviation of amino acid).
[0017] Experiments have proved that α9α10 acetylcholine receptor (nAChR) is one of the subtypes of acetylcholine receptors newly discovered in recent years. It is a target for the treatment of chronic pain and has obvious effects on pain caused by trauma and chemotherapy. The α-conotoxin Vc1.1 and RgIA exhibited strong activity in the mouse α9α10 nAChR, but when tested on the human α9α10 nAChR, the activity decreased significantly, b...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com